| # | Drug | Count |
|---|---|---|
| 0 | EVEROLIMUS | 11 |
| 1 | LANREOTIDE ACETATE | 11 |
| 2 | CYCLOPHOSPHAMIDE | 10 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 5 | METOCLOPRAMIDE | 10 |
| 6 | METOCLOPRAMIDE HYDROCHLORIDE | 10 |
| 7 | AMLODIPINE BESYLATE | 9 |
| 8 | LOPERAMIDE HCL | 9 |
| 9 | LOPERAMIDE HYDROCHLORIDE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEBENTAFUSP | 1 | 0.0017 |
| 1 | ADEFOVIR DIPIVOXIL | 2 | 0.0016 |
| 2 | BREXUCABTAGENE AUTOLEUCEL | 3 | 0.0014 |
| 3 | LANREOTIDE ACETATE | 11 | 0.0014 |
| 4 | MOSUNETUZUMAB | 1 | 0.0009 |
| 5 | AXICABTAGENE CILOLEUCEL | 8 | 0.0008 |
| 6 | LOPERAMIDE HCL | 9 | 0.0007 |
| 7 | CILTACABTAGENE AUTOLEUCEL | 4 | 0.0006 |
| 8 | GLOFITAMAB | 1 | 0.0004 |
| 9 | LANADELUMAB-FLYO | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 1 | 0.0017 |
| 1 | CD19-directed Chimeric Antigen Receptor [EPC] | 8 | 0.0008 |
| 2 | Human C1 Esterase Inhibitor [EPC] | 2 | 0.0005 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 4 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 5 | Anti-anginal [EPC] | 1 | 0.0001 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 7 | Serotonin-3 Receptor Antagonist [EPC] | 9 | 0.0001 |
| 8 | Cholinesterase Inhibitor [EPC] | 1 | 0.0001 |
| 9 | Alkylating Drug [EPC] | 10 | 0.0000 |